Pazzagli, Laura http://orcid.org/0000-0002-1908-6073
Brandt, Lena
Linder, Marie
Myers, David
Mavros, Panagiotis
Andersen, Morten
Bahmanyar, Shahram
Funding for this research was provided by:
public‐private real world evidence collaboration between Karolinska Institutet and Janssen Pharmaceuticals (5‐63/2015)
Novo Nordisk Foundation (NNF15SA0018404)
Article History
Received: 22 March 2019
Accepted: 10 October 2019
First Online: 22 November 2019
Compliance with ethical standards
:
: The Centre for Pharmacoepidemiology receives grants from several entities (pharmaceutical companies, regulatory authorities, and contract research organizations) for performance of drug safety and drug utilization studies. Morten Andersen reports grants from Novartis, Pfizer, AstraZeneca and H. Lundbeck & Mertz outside the submitted work, and personal fees from Atrium, the Danish Pharmaceutical Industry Association, for leading and teaching pharmacoepidemiology courses. Panagiotis Mavros is employee of Janssen Scientific Affairs, Titusville, NJ, USA. David Myers is employee of The Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Cilag AB, Stockholm, Sweden. The authors declare no other conflict of interest.